Efficacy and safety of 120-W thulium:yttrium-aluminum-garnet vapoenucleation of prostates compared with holmium laser enucleation of prostates for benign prostatic hyperplasia.
Identifieur interne : 000094 ( PubMed/Corpus ); précédent : 000093; suivant : 000095Efficacy and safety of 120-W thulium:yttrium-aluminum-garnet vapoenucleation of prostates compared with holmium laser enucleation of prostates for benign prostatic hyperplasia.
Auteurs : Kai Hong ; Yu-Qing Liu ; Jian Lu ; Chun-Lei Xiao ; Yi Huang ; Lu-Lin MaSource :
- Chinese medical journal [ 0366-6999 ] ; 2015.
English descriptors
- KwdEn :
- MESH :
- chemical , therapeutic use : Aluminum, Thulium, Yttrium.
- surgery : Prostate, Prostatic Hyperplasia.
- Aged, Humans, Laser Therapy, Male, Middle Aged, Quality of Life, Retrospective Studies, Treatment Outcome.
Abstract
This study compared the efficacy and safety between 120-W thulium:yttrium-aluminum-garnet (Tm:YAG) vapoenucleation of prostates (ThuVEP) and holmium laser enucleation of prostates (HoLEP) for patients with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH).
DOI: 10.4103/0366-6999.154282
PubMed: 25836607
Links to Exploration step
pubmed:25836607Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Efficacy and safety of 120-W thulium:yttrium-aluminum-garnet vapoenucleation of prostates compared with holmium laser enucleation of prostates for benign prostatic hyperplasia.</title><author><name sortKey="Hong, Kai" sort="Hong, Kai" uniqKey="Hong K" first="Kai" last="Hong">Kai Hong</name></author><author><name sortKey="Liu, Yu Qing" sort="Liu, Yu Qing" uniqKey="Liu Y" first="Yu-Qing" last="Liu">Yu-Qing Liu</name><affiliation><nlm:affiliation>Department of Urology, Peking University Third Hospital, Beijing 100191, China.</nlm:affiliation></affiliation></author><author><name sortKey="Lu, Jian" sort="Lu, Jian" uniqKey="Lu J" first="Jian" last="Lu">Jian Lu</name></author><author><name sortKey="Xiao, Chun Lei" sort="Xiao, Chun Lei" uniqKey="Xiao C" first="Chun-Lei" last="Xiao">Chun-Lei Xiao</name></author><author><name sortKey="Huang, Yi" sort="Huang, Yi" uniqKey="Huang Y" first="Yi" last="Huang">Yi Huang</name></author><author><name sortKey="Ma, Lu Lin" sort="Ma, Lu Lin" uniqKey="Ma L" first="Lu-Lin" last="Ma">Lu-Lin Ma</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="doi">10.4103/0366-6999.154282</idno><idno type="RBID">pubmed:25836607</idno><idno type="pmid">25836607</idno><idno type="wicri:Area/PubMed/Corpus">000094</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000094</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Efficacy and safety of 120-W thulium:yttrium-aluminum-garnet vapoenucleation of prostates compared with holmium laser enucleation of prostates for benign prostatic hyperplasia.</title><author><name sortKey="Hong, Kai" sort="Hong, Kai" uniqKey="Hong K" first="Kai" last="Hong">Kai Hong</name></author><author><name sortKey="Liu, Yu Qing" sort="Liu, Yu Qing" uniqKey="Liu Y" first="Yu-Qing" last="Liu">Yu-Qing Liu</name><affiliation><nlm:affiliation>Department of Urology, Peking University Third Hospital, Beijing 100191, China.</nlm:affiliation></affiliation></author><author><name sortKey="Lu, Jian" sort="Lu, Jian" uniqKey="Lu J" first="Jian" last="Lu">Jian Lu</name></author><author><name sortKey="Xiao, Chun Lei" sort="Xiao, Chun Lei" uniqKey="Xiao C" first="Chun-Lei" last="Xiao">Chun-Lei Xiao</name></author><author><name sortKey="Huang, Yi" sort="Huang, Yi" uniqKey="Huang Y" first="Yi" last="Huang">Yi Huang</name></author><author><name sortKey="Ma, Lu Lin" sort="Ma, Lu Lin" uniqKey="Ma L" first="Lu-Lin" last="Ma">Lu-Lin Ma</name></author></analytic><series><title level="j">Chinese medical journal</title><idno type="ISSN">0366-6999</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Aluminum (therapeutic use)</term><term>Humans</term><term>Laser Therapy</term><term>Male</term><term>Middle Aged</term><term>Prostate (surgery)</term><term>Prostatic Hyperplasia (surgery)</term><term>Quality of Life</term><term>Retrospective Studies</term><term>Thulium (therapeutic use)</term><term>Treatment Outcome</term><term>Yttrium (therapeutic use)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Aluminum</term><term>Thulium</term><term>Yttrium</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Prostate</term><term>Prostatic Hyperplasia</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Humans</term><term>Laser Therapy</term><term>Male</term><term>Middle Aged</term><term>Quality of Life</term><term>Retrospective Studies</term><term>Treatment Outcome</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">This study compared the efficacy and safety between 120-W thulium:yttrium-aluminum-garnet (Tm:YAG) vapoenucleation of prostates (ThuVEP) and holmium laser enucleation of prostates (HoLEP) for patients with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH).</div></front></TEI><pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">25836607</PMID><DateCreated><Year>2015</Year><Month>04</Month><Day>03</Day></DateCreated><DateCompleted><Year>2015</Year><Month>09</Month><Day>28</Day></DateCompleted><DateRevised><Year>2016</Year><Month>05</Month><Day>04</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0366-6999</ISSN><JournalIssue CitedMedium="Internet"><Volume>128</Volume><Issue>7</Issue><PubDate><Year>2015</Year><Month>Apr</Month><Day>5</Day></PubDate></JournalIssue><Title>Chinese medical journal</Title><ISOAbbreviation>Chin. Med. J.</ISOAbbreviation></Journal><ArticleTitle>Efficacy and safety of 120-W thulium:yttrium-aluminum-garnet vapoenucleation of prostates compared with holmium laser enucleation of prostates for benign prostatic hyperplasia.</ArticleTitle><Pagination><MedlinePgn>884-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.4103/0366-6999.154282</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">This study compared the efficacy and safety between 120-W thulium:yttrium-aluminum-garnet (Tm:YAG) vapoenucleation of prostates (ThuVEP) and holmium laser enucleation of prostates (HoLEP) for patients with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A retrospective analysis of 88 consecutive patients with symptomatic BPH was carried out, who underwent either 120-W ThuVEP or HoLEP nonrandomly. Patient demographics and peri-operative and 12-month follow-up data were analyzed with the International Prostate Symptom Score (IPSS), quality of life (QoL) score, maximum flow rate (Qmax), postvoid residual urine volume (PVR), and rates of peri-operative and late complications.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The patients in each group showed no significant difference in preoperative parameters. Compared with the HoLEP group, patients in the 120-W ThuVEP group required significantly shorter time for laser enucleation (58.3 ± 12.8 min vs. 70.5 ± 22.3 min, P = 0.003), and resulted in a significant superiority in laser efficiency (resected prostate weight/laser enucleation time) for 120-W Tm:YAG laser compared to holmium:YAG laser (0.69 ± 0.18 vs. 0.61 ± 0.19, P = 0.048). During 1, 6, and 12 months of follow-ups, the procedures did not demonstrate a significant difference in IPSS, QoL score, Qmax, or PVR (P > 0.05). Mean peri-operative decrease of hemoglobin in the HoLEP group was similar to the ThuVEP group (17.1 ± 12.0 g/L vs. 15.2 ± 10.1 g/L, P = 0.415). Early and late incidences of complications were low and did not differ significantly between the two groups of 120-W ThuVEP and HoLEP patients (P > 0.05).</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">120-W ThuVEP and HoLEP are potent, safe and efficient modalities of minimally invasive surgeries for patients with LUTS due to BPH. Compared with HoLEP, 120-W ThuVEP offers advantages of reduction of laser enucleation time and improvement of laser efficiency.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Hong</LastName><ForeName>Kai</ForeName><Initials>K</Initials></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yu-Qing</ForeName><Initials>YQ</Initials><AffiliationInfo><Affiliation>Department of Urology, Peking University Third Hospital, Beijing 100191, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lu</LastName><ForeName>Jian</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Chun-Lei</ForeName><Initials>CL</Initials></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Yi</ForeName><Initials>Y</Initials></Author><Author ValidYN="Y"><LastName>Ma</LastName><ForeName>Lu-Lin</ForeName><Initials>LL</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>China</Country><MedlineTA>Chin Med J (Engl)</MedlineTA><NlmUniqueID>7513795</NlmUniqueID><ISSNLinking>0366-6999</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C503779">yttrium-aluminum-garnet</NameOfSubstance></Chemical><Chemical><RegistryNumber>58784XQC3Y</RegistryNumber><NameOfSubstance UI="D015019">Yttrium</NameOfSubstance></Chemical><Chemical><RegistryNumber>8RKC5ATI4P</RegistryNumber><NameOfSubstance UI="D013932">Thulium</NameOfSubstance></Chemical><Chemical><RegistryNumber>CPD4NFA903</RegistryNumber><NameOfSubstance UI="D000535">Aluminum</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>Curr Opin Urol. 2009 Jan;19(1):38-43</RefSource><PMID Version="1">19057214</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World J Urol. 2010 Feb;28(1):39-43</RefSource><PMID Version="1">19669645</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Urol. 2010 Mar;183(3):1105-9</RefSource><PMID Version="1">20092844</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BJU Int. 2010 Aug;106(3):368-72</RefSource><PMID Version="1">19912204</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chin Med J (Engl). 2010 Sep;123(17):2370-4</RefSource><PMID Version="1">21034551</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BJU Int. 2011 Feb;107(3):433-7</RefSource><PMID Version="1">20804474</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BJU Int. 2011 Apr;107(7):1030-43</RefSource><PMID Version="1">21438974</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Urol. 2011 Dec;186(6):2323-7</RefSource><PMID Version="1">22014812</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Urol. 2012 Feb;61(2):317-25</RefSource><PMID Version="1">22033173</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BJU Int. 2012 Feb;109(3):408-11</RefSource><PMID Version="1">21883820</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Urol. 2012 Apr;61(4):783-95</RefSource><PMID Version="1">22285403</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Asian J Androl. 2012 Mar;14(2):325-9</RefSource><PMID Version="1">22231295</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Urology. 2012 Apr;79(4):869-74</RefSource><PMID Version="1">22342411</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BJU Int. 2012 Jul;110(1):96-101</RefSource><PMID Version="1">22085294</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chin Med J (Engl). 2012 May;125(9):1536-41</RefSource><PMID Version="1">22800817</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chin Med J (Engl). 2012 Nov;125(21):3778-81</RefSource><PMID Version="1">23106872</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Chin Med J (Engl). 2012 Nov;125(21):3811-4</RefSource><PMID Version="1">23106879</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>J Urol. 2013 Jan;189(1):217-22</RefSource><PMID Version="1">23174256</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>BJU Int. 2012 Dec;110(11 Pt C):E845-50</RefSource><PMID Version="1">22702908</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Urol. 2013 May;63(5):859-67</RefSource><PMID Version="1">23245687</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World J Urol. 2013 Oct;31(5):1231-8</RefSource><PMID Version="1">22733237</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Urology. 2014 Jan;83(1):175-80</RefSource><PMID Version="1">24103563</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World J Urol. 2014 Feb;32(1):165-72</RefSource><PMID Version="1">23657354</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>World J Urol. 2014 Dec;32(6):1551-8</RefSource><PMID Version="1">24531878</PMID></CommentsCorrections><CommentsCorrections RefType="Cites"><RefSource>Eur Urol. 2015 Jun;67(6):1066-96</RefSource><PMID Version="1">24972732</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000368">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D000535">Aluminum</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D053685">Laser Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D008875">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D011467">Prostate</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D011470">Prostatic Hyperplasia</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D011788">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D012189">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D013932">Thulium</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D016896">Treatment Outcome</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D015019">Yttrium</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000627">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><OtherID Source="NLM">PMC4834003</OtherID></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2015</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2015</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>9</Month><Day>29</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pii">ChinMedJ_2015_128_7_884_154282</ArticleId><ArticleId IdType="doi">10.4103/0366-6999.154282</ArticleId><ArticleId IdType="pubmed">25836607</ArticleId><ArticleId IdType="pmc">PMC4834003</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Terre/explor/ThuliumV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000094 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000094 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Terre
|area= ThuliumV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:25836607
|texte= Efficacy and safety of 120-W thulium:yttrium-aluminum-garnet vapoenucleation of prostates compared with holmium laser enucleation of prostates for benign prostatic hyperplasia.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:25836607" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a ThuliumV1
| This area was generated with Dilib version V0.6.21. |  |